EUVIMEDEUVIMED entdecken
Crossref

Structure‐Based Identification and Molecular Characterization of CID‐2135609 as a Potent Small Molecule Modulator of HIV‐1 Protease

S Rehan Ahmad iD, Md Zeyaullah, Abdullah M AlShahrani iD, Ali Mohieldin iD, Mohammad Shane Alam, Abdelrhman A G Altijani iD

Journal of Cellular Biochemistry · 2025

DOI: 10.1002/jcb.70058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Biochemistry, 2025. Verfasst von S Rehan Ahmad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hiralal Mazumdar Memorial College for Women, West Bengal State University, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: HIV Protease, HIV Protease Inhibitors, HIV-1, Small Molecule Libraries. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Large Research P….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV‐1 protease is a key therapeutic target for antiretroviral drug development. In this study, a structure‐based high‐throughput virtual screening (HTVS) approach was employed to identify novel quinazoline‐based inhibitors targeting the protease's catalytic site. A library of 5000 compounds from the PubChem database was screened, and CID‐2135609 emerged as the top hit with the strongest binding affinity (–12.39 kcal/mol). In addition to its superior docking score, CID‐2135609 exhibited favorable drug‐like properties, including optimal molecular weight, high Caco‐2 permeability, balanced lipophilicity, and acceptable blood‐brain barrier penetration. Molecular docking revealed that CID‐2135609 engages key catalytic residues (Asp25, Ile50, Gly49) through van der Waals and π‐interactions, with additional contributions from Arg8, Asp30, and Ile47. Thermodynamic profiling indicated that binding is exothermic and entropically favorable, driven by hydrophobic contacts and water displacement, with a negative ΔG confirming spontaneous association. All‐atom molecular dynamics simulations over 200 ns demonstrated that CID‐2135609 maintains stable binding within the active site, preserving critical contacts while adapting its orientation to enhance fit. The protease structure remained conformationally stable, with minimal deviation in secondary structure or global compactness. Time‐resolved interaction profiling revealed sustained and expanded interactions with residues including Pro81, Ile84, and Thr80. Comparative analysis with the apo form showed reduced solvent exposure and conformational flexibility upon ligand binding, as supported by SASA and PCA analyses. Free energy decomposition further validated complex stability. Overall, CID‐2135609 is a promising candidate for HIV‐1 protease inhibition and merits further experimental validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV ProteaseHIV Protease InhibitorsHIV-1Small Molecule LibrariesHumansMolecular Docking SimulationCaco-2 CellsCatalytic DomainMolecular Dynamics Simulation

Stichwörter der Autor:innen

HIV‐1 proteasemolecular dockingmolecular dynamics simulationquinazoline inhibitorsstructure‐based drug design

Substanzen

HIV Proteasep16 protease, Human immunodeficiency virus 1HIV Protease InhibitorsSmall Molecule Libraries

Autor:innen und Institutionen

  • Hiralal Mazumdar Memorial College for Women, West Bengal State University, Kolkata, West Bengal, India.
  • Department of Basic Medical Science, College of Applied Medical Sciences, Khamis Mushayt Campus, King Khalid University, Abha, Saudi Arabia.
  • Department of Public Health, College of Applied Medical Sciences, Khamis Mushait Campus, King Khalid University, Abha, Saudi Arabia.
  • Department of Medical Laboratory Technology, College of Applied Medical Sciences, Jazan University, Jazan, Saudi Arabia.

ORCID-Profile: S Rehan Ahmad, Abdullah M AlShahrani, Ali Mohieldin, Abdelrhman A G Altijani

Förderung

  • The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Large Research P…

Zitieren

APA

Rehan Ahmad, S., Zeyaullah, M., AlShahrani, A. M., Mohieldin, A., Alam, M. S., & Altijani, A. A. G. (2025). Structure‐Based Identification and Molecular Characterization of CID‐2135609 as a Potent Small Molecule Modulator of HIV‐1 Protease. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.70058

Vancouver

Rehan Ahmad S, Zeyaullah M, AlShahrani AM, Mohieldin A, Alam MS, Altijani AAG. Structure‐Based Identification and Molecular Characterization of CID‐2135609 as a Potent Small Molecule Modulator of HIV‐1 Protease. Journal of Cellular Biochemistry. 2025. doi:10.1002/jcb.70058

BibTeX
@article{RehanAhmad2025,
  author = {Rehan Ahmad, S and Zeyaullah, Md and AlShahrani, Abdullah M and Mohieldin, Ali and Alam, Mohammad Shane and Altijani, Abdelrhman A G},
  title = {Structure‐Based Identification and Molecular Characterization of CID‐2135609 as a Potent Small Molecule Modulator of HIV‐1 Protease},
  journal = {Journal of Cellular Biochemistry},
  year = {2025},
  doi = {10.1002/jcb.70058}
}
Kostenlos starten →